|
Volumn 151, Issue 3, 2011, Pages 385-387
|
Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes
|
Author keywords
Acute coronary syndrome; GP IIb IIIa antagonism; Inflammation; Platelets
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CD40 LIGAND;
CXCL1 CHEMOKINE;
DICKKOPF 1 PROTEIN;
EPTIFIBATIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MACROPHAGE INFLAMMATORY PROTEIN 1BETA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PLACEBO;
RANTES;
TUMOR NECROSIS FACTOR RECEPTOR 1;
ACUTE CORONARY SYNDROME;
ADULT;
CLINICAL ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG USE;
FEMALE;
HUMAN;
HYPERTENSION;
INFLAMMATION;
LETTER;
MALE;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROTEIN BLOOD LEVEL;
THROMBOCYTE;
|
EID: 80052719838
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2011.06.117 Document Type: Article |
Times cited : (5)
|
References (9)
|